Recombinant Macaca fascicularis G-protein coupled receptor 1 (GPR1)

What is GPR1 and what is its biological significance in Macaca fascicularis?

GPR1 (G-protein coupled receptor 1) is a seven-transmembrane domain receptor belonging to the G-protein coupled receptor superfamily. In Macaca fascicularis, GPR1 functions as a chemokine receptor involved in cell signaling pathways. Research indicates that GPR1 is expressed in various tissues including brain progenitor cells, suggesting its role in neural development and function. The receptor has been identified as being expressed in brain progenitor cells isolated from embryonic brain of cynomolgus monkeys (Macaca fascicularis) alongside other receptors such as CD4, CXCR4, CCR5, STRL33, and APJ . This expression pattern suggests GPR1 may participate in complex signaling networks within the developing and mature brain.

How can researchers distinguish between GPR1 and other closely related G-protein coupled receptors in experimental systems?

Distinguishing GPR1 from other closely related receptors requires a multi-faceted approach:

• Sequence-based identification: Use primers specific to the GPR1 sequence (such as the one identified in the product database: full-length protein spanning region 1-355) .

• Antibody specificity: Employ antibodies that target unique epitopes of GPR1 not shared with other GPCRs.

• Functional assays: Utilize ligand binding specificity and downstream signaling patterns that are unique to GPR1.

• Expression pattern analysis: Compare tissue distribution profiles, as GPR1 has a characteristic expression pattern in neural tissues of Macaca fascicularis.

When conducting RT-PCR or immunohistochemistry, researchers should always include appropriate controls to verify specificity, particularly when studying tissues known to express multiple GPCR types.

What are the known expression patterns of GPR1 in different tissues of Macaca fascicularis?

Based on current research findings, GPR1 expression in Macaca fascicularis has been documented in:

• Brain progenitor cells (BPCs): Expression confirmed through RT-PCR analysis in both undifferentiated and differentiated BPCs isolated from embryonic brain .

• Neural tissues: Expression detected in cells derived from brain progenitor cells that have been induced to differentiate.

The expression of GPR1 alongside other receptors such as CD4, CXCR4, and CCR5 in brain cells suggests potential roles in neuroimmune interactions and possibly viral neurotropism . More comprehensive tissue expression profiling would require additional research beyond what is currently available in the literature.

What are the optimal conditions for working with recombinant Macaca fascicularis GPR1 in vitro?

When working with recombinant Macaca fascicularis GPR1, researchers should consider the following methodological aspects:

Storage and Handling:

• Store recombinant protein at -20°C or -80°C for extended storage

• Avoid repeated freeze-thaw cycles; prepare working aliquots stored at 4°C for up to one week

• Use Tris-based buffer with 50% glycerol as optimal storage medium

Expression Systems:

• Mammalian expression systems (such as HEK293 or CHO cells) typically yield properly folded GPCRs with appropriate post-translational modifications

• Consider using inducible expression systems to control expression levels

• For membrane preparation, use buffers containing protease inhibitors to prevent degradation

Functional Assays:

• Maintain physiological pH (7.2-7.4) and temperature (37°C) during binding and signaling assays

• Include appropriate positive controls (known ligands) and negative controls in all assays

• Consider the impact of tags (His, FLAG, etc.) on receptor functionality; C-terminal tags are generally less disruptive to GPCR function than N-terminal modifications

How can researchers validate the functionality of recombinant Macaca fascicularis GPR1 after expression?

Validating GPR1 functionality requires multiple approaches:

• Ligand Binding Assays:

  • Radioligand binding using known ligands if available

  • Competition binding assays to determine binding affinities

  • Saturation binding to determine receptor density

• Signaling Assays:

  • cAMP accumulation or inhibition (depending on G-protein coupling)

  • Calcium mobilization assays using fluorescent indicators

  • β-arrestin recruitment assays

  • ERK phosphorylation measurements

• Receptor Trafficking Studies:

  • Surface expression quantification using flow cytometry

  • Internalization assays using fluorescently-labeled antibodies or ligands

  • Recycling studies to assess receptor dynamics

• Structural Validation:

  • Western blotting to confirm expression of full-length protein (46.4 kDa for similar GPCRs)

  • Glycosylation analysis to verify post-translational modifications

  • Circular dichroism or other spectroscopic methods to assess proper folding

A comprehensive validation should include at least one assay from each category to ensure both expression and functionality of the recombinant GPR1.

What considerations should be made when designing GPR1 knockout or overexpression experiments in Macaca fascicularis cells?

When designing genetic manipulation experiments for GPR1 in Macaca fascicularis cells:

For Knockout Approaches:

• Consider CRISPR/Cas9 targeting of conserved regions within the GPR1 coding sequence

• Design multiple guide RNAs to increase efficiency

• Validate knockout using both genomic sequencing and protein expression analysis

• Include off-target analysis, particularly for related GPCR family members

• Establish appropriate control cell lines (non-targeting gRNA)

For Overexpression Studies:

• Select appropriate promoters (constitutive vs. inducible)

• Consider codon optimization for Macaca fascicularis cells

• Include epitope tags that don't interfere with receptor function

• Quantify expression levels and compare to endogenous expression

• Control for potential artifacts from overexpression (mislocalization, constitutive activity)

Functional Validation:

• Compare wild-type, knockout, and rescue phenotypes

• Assess both basal and stimulated signaling

• Examine potential compensatory mechanisms (upregulation of related GPCRs)

• Analyze downstream signaling pathways and biological outcomes

• Consider single-cell analysis to account for heterogeneity in expression

How does viral infection affect GPR1 expression and function in Macaca fascicularis neural cells?

Research using brain progenitor cells (BPCs) from Macaca fascicularis has demonstrated connections between viral infection and GPR1 expression:

• Expression in Susceptible Cells: GPR1 is expressed alongside other receptors (CD4, CXCR4, CCR5) in brain progenitor cells that are susceptible to SIV infection, suggesting potential roles in viral neurotropism .

• Infection Dynamics: When studying viral effects on GPR1:

  • Establish baseline GPR1 expression before infection

  • Monitor expression changes at multiple time points post-infection

  • Compare effects across different viral strains (e.g., neurotropic vs. non-neurotropic)

  • Examine cell-type specific responses in heterogeneous neural cultures

• Methodological Approaches:

  • Use quantitative RT-PCR to measure changes in GPR1 mRNA levels

  • Perform immunocytochemistry to examine receptor localization changes

  • Employ signaling assays to determine functional alterations

  • Implement receptor trafficking studies to assess internalization patterns

• Research Significance: Understanding how viral infection modulates GPR1 might provide insights into mechanisms of viral neuropathogenesis. The BPC-derived cell culture system offers a valuable model for studying these interactions in a controlled environment free from confounding factors like macrophages/microglial cells .

What role might GPR1 play in neural development based on its expression in Macaca fascicularis brain progenitor cells?

The detection of GPR1 in brain progenitor cells suggests potential roles in neural development:

• Developmental Expression Pattern:

  • GPR1 is expressed in both undifferentiated and differentiated brain progenitor cells from embryonic Macaca fascicularis brain

  • This suggests potential functions in both proliferative progenitors and their differentiated progeny

• Research Approaches:

  • Temporal expression analysis during different developmental stages

  • Co-localization studies with developmental markers (nestin, GFAP, Tuj1)

  • Function-blocking experiments using antibodies or knockdown approaches

  • Ligand identification in developing neural tissues

• Potential Developmental Functions:

  • Migration regulation of neural progenitors

  • Differentiation fate determination

  • Axon guidance and synaptogenesis

  • Establishment of neural circuits

• Experimental Design Considerations:

  • Use developmentally staged tissues or time-course differentiation protocols

  • Compare expression between proliferative zones and areas of differentiation

  • Consider species differences when translating findings to human development

  • Employ 3D culture systems to better recapitulate in vivo development

How can comparative studies between Macaca fascicularis GPR1 and human GPR1 inform translational research?

Comparative studies between species provide valuable insights for translational applications:

• Sequence and Structural Comparison:

  • Align complete protein sequences to identify conserved functional domains

  • Focus on key regions: ligand binding pocket, G-protein coupling domains, phosphorylation sites

  • Model structural differences that might affect drug binding and signaling

• Functional Comparison:

  • Parallel signaling assays using identical experimental conditions

  • Comparative pharmacological profiling with panel of compounds

  • Evaluation of species-specific regulatory mechanisms

• Experimental Design Framework:

  • Express both receptors in identical cellular backgrounds

  • Use domain swapping to identify regions responsible for functional differences

  • Develop assays sensitive enough to detect subtle pharmacological differences

• Translational Relevance:

  • Data tables comparing key parameters between species:

This comparative approach helps researchers determine how findings in Macaca fascicularis models might translate to human applications, particularly for drug development targeting GPR1.

How can researchers resolve inconsistent results in GPR1 signaling assays?

When facing inconsistent results in GPR1 signaling experiments, consider these methodological approaches:

• Receptor Expression Variability:

  • Quantify receptor expression levels between experiments

  • Implement stable cell lines with controlled expression

  • Consider using inducible systems to standardize expression

• Assay Optimization:

  • Standardize cell density, passage number, and culture conditions

  • Optimize ligand concentrations and exposure times

  • Control for receptor desensitization in repeated stimulation protocols

• Technical Considerations:

  • Validate antibody specificity through multiple approaches

  • Prepare consistent membrane fractions for binding assays

  • Use internal standards in each experiment

• Systematic Troubleshooting Approach:

• Data Analysis Approaches:

  • Normalize data to positive controls run in parallel

  • Apply appropriate statistical tests for comparing treatments

  • Consider Bayesian analysis for integrating results across experiments

  • Implement quality control thresholds for inclusion of experimental replicates

What statistical methods are most appropriate for analyzing GPR1 functional data?

• Dose-Response Analysis:

  • Nonlinear regression for calculating EC50/IC50 values

  • Four-parameter logistic model for full curves

  • Consider variable slope models when appropriate

  • Bootstrap methods for confidence interval estimation

• Receptor Binding Studies:

  • Scatchard analysis or nonlinear regression for Kd determination

  • Statistical comparison of binding parameters across conditions

  • Multiple comparison corrections for screening studies

• Time-Course Experiments:

  • Repeated measures ANOVA for comparing treatments over time

  • Area under the curve (AUC) analysis for response quantification

  • Mixed-effects models for handling missing data points

• Comparison Across Experimental Conditions:

  • ANOVA with appropriate post-hoc tests for multiple comparisons

  • Non-parametric alternatives when normality assumptions are violated

  • Consider power analysis to determine adequate sample sizes

• Advanced Analytical Approaches:

  • Principal component analysis for complex signaling datasets

  • Cluster analysis for identifying response patterns

  • Machine learning approaches for predicting ligand activities

  • Pathway analysis for contextualizing GPR1 signaling within broader networks

When publishing GPR1 research findings, clearly describe all statistical methods, include appropriate visualizations, and report both statistical significance and effect sizes to facilitate interpretation and reproducibility.